Principal Technologies IncTSXV:PTEC
- LAST PRICE0.1650
- TODAY'S CHANGE (%)-0.0050 (-2.9412%)
- Bid / Lots0.1000/ 20
- Ask / Lots0.1700/ 35
- Open / Previous Close0.1650 / 0.1700
- Day Range
- 52 Week Range
- Volume20,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PTEC |
|---|---|---|
| 03:51 ET | 20000 | 0.165 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Principal Technologies Inc | 6.3M | -2.2x | --- |
Glow Lifetech Corp | 6.1M | -1.6x | --- |
Marvel Biosciences Corp | 6.0M | -2.6x | --- |
Rakovina Therapeutics Inc | 7.2M | -1.9x | --- |
Quest Pharmatech Inc | 5.1M | 0.4x | --- |
Awakn Life Sciences Corp | 4.6M | -1.2x | --- |
Company Information
Principal Technologies Inc. is a Canada-based company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. It operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The Company's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Contact Information
- Headquarters
- 2500 - 700 West Georgia StreetVancouver, BC, Canada V7Y 1B3
- Phone
- 604-609-6112
- Fax
- 604-609-6145
Executives
- Chief Executive Officer, Director
- Gerald Trent
- Chief Financial Officer, Corporate Secretary
- Peter Mckeown
- Independent Director
- Leopold Specht
- Independent Director
- Alfred Von Liechtenstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.3M |
|---|---|
Revenue (TTM) | $618.6K |
Shares Outstanding | 36.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.08 |
Book Value | $0.01 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 10.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -286.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
